Alexander Sah, MD
Adult Reconstructive Orthopaedic Surgery · Fremont, CANPI 1003966359
Payments from drug & device makers
Across 1,107 payments — averaging $1635.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Microport Orthopedics Inc$371K
- Zimmer Biomet$313K
- Heron Therapeutics, Inc.$294K
- Pacira Pharmaceuticals Incorporated$172K
- Smith+Nephew$102K
- Exactech, Inc.$101K
- plus $458K from 39 others
Across 1 payment — averaging $10,000 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$10K
What the payments were for
- Royalty or licence$115,58210%
- Consulting fees$505,12442%
- Speaking & faculty fees$434,97736%
- Travel & lodging$68,0696%
- Food & beverage$20,6682%
- Education$50,6764%
- Gifts$880%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Zynrelef$275,933
- EXPAREL$143,142
- MPO Medial Pivot Knee$117,474
- iNSitu Hip System$58,582
- TRULIANT$55,008
- AQUAMANTYS$49,745
- PALACOS$44,894
- Tsolution One Surgical System$44,450
- JOURNAVX$38,777
- APONVIE$31,621
- OFIRMEV$29,522
- NA$27,274
- MPO Hip System$25,092
- OPTETRAK$14,125
- HTX-011$13,836
- Skywalker$11,912
- ALTEON$11,830
- AQUACEL AG$9,876
- GRPRO 2.1$9,724
- ROSA$8,160
How this compares
$1,810,915 in reported general payments places this provider in the 95th percentile of 136 adult reconstructive orthopaedic surgery providers in California.
See all adult reconstructive orthopaedic surgery providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 69 | $4,623 |
| Amoxicillin | 428 | $1,196 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 36 | $708 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 42 | $598 |
| Doxycycline Monohydrate | 13 | $423 |
| Clindamycin Hcl | 83 | $266 |
| Cephalexin | 19 | $225 |
| Ondansetron Hcl | 14 | $119 |
| Tramadol Hcl | 18 | $76 |
| Metronidazole | 22 | $21 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Fremont
- William MaloneyStanford$11.1M
- James CaillouetteNewport Beach$4.8M
- William LongLos Angeles$2.8M
- John DearbornMenlo Park$2.5M
- James HuddlestonStanford$2.2M
- William Bugbeela Jolla$2.2M
- John DianaNapa$1.1M
- Louis KwongTorrance$958K
- Derek AmanatullahStanford$935K
- Thomas DonaldsonColton$893K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.